Skip to main content
  • Combo Tx Boosts Kidney Function in Chronic HFrEF

    Sacubitril/valsartan bests valsartan alone in analysis of patients in PARAGON-HF trial

    WASHINGTON -- Combination sacubitril and valsartan (Entresto) was associated with significantly fewer renal outcomes than valsartan alone among patients with heart failure (HF) and preserved ejection fraction (HFrEF), a researcher said here.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details